Boston Scientific's Total Assets for the quarter that ended in Sep. 2024 was MXN749,767 Mil.
Warning Sign:
If a company builds assets at 7.8% a year, faster than its revenue growth rate of 6.6% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Boston Scientific's average Total Assets Growth Rate was 7.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 5.70% per year.
During the past 5 years, the average Total Assets Growth Rate was 7.80% per year.
During the past 10 years, the average Total Assets Growth Rate was 8.90% per year.
During the past 13 years, Boston Scientific's highest 3-Year average Total Assets Growth Rate was 80.20%. The lowest was -11.30%. And the median was 13.80%.
The historical data trend for Boston Scientific's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Boston Scientific's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (MEX:BSX) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Sep. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Boston Scientific's Asset Turnover for the quarter that ended in Sep. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Boston Scientific Total Assets Related Terms
Thank you for viewing the detailed overview of Boston Scientific's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MEX:BSX has been successfully added to your 